Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Regencell Bioscience Holdings Ltd RGC

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.


NDAQ:RGC - Post by User

User Avatar Image
(0)
•••
  • sungrin1309X
Post by sungrin1309on Nov 17, 2022 2:28am
250 Views
Post# 35105793

$RGC Founder; Yat-Gai Au, Just Bought A Few More Shares

$RGC Founder; Yat-Gai Au, Just Bought A Few More SharesThose following along with Regencell Bioscience Holdings Limited will no doubt be intrigued by the recent purchase of shares by Yat-Gai Au, Founder of the company, who spent a stonking US$1.2m on stock at an average price of US$25.23. While that only increased their holding size by 0.5%, it is still a big swing by our standards.


Regencell Bioscience Holdings Insider Transactions Over The Last Year
In fact, the recent purchase by Yat-Gai Au was the biggest purchase of Regencell Bioscience Holdings shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of US$24.86. It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Yat-Gai Au was the only individual insider to buy shares in the last twelve months.

Yat-Gai Au purchased 68.34k shares over the year. The average price per share was US$26.03. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below.

https://finance.yahoo.com/news/founder-regencell-bioscience-holdings-limited-101443485.html
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities